Nora Lee

The Royal Melbourne Hospital — Australia

Medicine · Health Sciences

19h-index996citations76works7.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Acute Ischemic Stroke Management(12), Drug Transport and Resistance Mechanisms(9), Stroke Rehabilitation and Recovery(8), Cerebrovascular and Carotid Artery Diseases(7), Diabetes Treatment and Management(5)

Publications76 total

Uptake of gonadotrophin‐releasing hormone agonists for prevention of premature ovarian insufficiency in women undergoing chemotherapy: an <scp>Australian</scp> single‐centre study
Internal Medicine Journal·2024Open Access
Clinical outcomes of chronic myeloid leukaemia patients taking asciminib through a Managed Access Programme (MAP) in Australia
Internal Medicine Journal·2024· 5 citedOpen Access
Patient-specific tissue engineered vascular graft for aortic arch reconstruction
JTCVS Open·2024· 3 citedOpen Access
Thrombosis in patients with immune thrombocytopenia: incidence, risk, and clinical outcomes
Research and Practice in Thrombosis and Haemostasis·2024· 22 citedOpen Access
Risk-Directed Ambulatory Thromboprophylaxis in Lung and Gastrointestinal Cancers
JAMA Oncology·2023· 28 citedOpen Access
Validity of Customized Branched Tissue Engineered Vascular Graft in a Porcine Model
Annals of Thoracic Surgery Short Reports·2023· 2 citedOpen Access
Awareness, preferences, and experiences of thrombosis and thromboprophylaxis in adults commencing systemic anticancer therapies: TARGET-TP trial.
Journal of Clinical Oncology·2023
Clinical Outcomes of Chronic Myeloid Leukaemia (CML) Patients on Asciminib through the Managed Access Program (MAP) in Australia
Blood·2022· 6 cited
Abstract 13000: The Effect of Flow Dynamics on the Neotissue Formation of 3D Printed Tissue Engineered Vascular Graft
Circulation·2022
Model-Based Prediction of Acid Suppression and Proposal of a New Dosing Regimen of Fexuprazan in Humans
Pharmaceuticals·2022· 9 citedOpen Access
Risk assessment model potency to detect patients most likely to benefit from thromboprophylaxis: An application of the TARGET-TP score.
Journal of Clinical Oncology·2022· 2 cited
Cover Image, Volume 24, Issue 3
Diabetes Obesity and Metabolism·2022
A Randomized, Double-Blind, Placebo- and Active-Controlled, Escalating Single-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Profiles of Subcutaneous Eflapegrastim in Healthy Japanese and Caucasian Subjects
Drugs in R&D·2022· 4 citedOpen Access
First in Human (FIH) FLT3 and SYK Inhibitor HM43239 Shows Single Agent Activity in Patients (pts) with Relapsed or Refractory (R/R) FLT3 Mutated and Wild-Type Acute Myeloid Leukemia (AML)
Blood·2021· 6 cited
A double‐blind, placebo‐controlled, single‐ascending dose study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of <scp>HM15136</scp> , a novel long‐acting glucagon analogue, in healthy subjects
Diabetes Obesity and Metabolism·2021· 6 cited
Author response for "A double‐blind, placebo‐controlled single ascending dose study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of HM15136 , a novel long‐acting glucagon analogue, in healthy subjects"
2021Open Access
Author response for "A double‐blind, placebo‐controlled single ascending dose study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of HM15136 , a novel long‐acting glucagon analogue, in healthy subjects"
2021
Development of Physiologically Based Pharmacokinetic Model for Orally Administered Fexuprazan in Humans
Pharmaceutics·2021· 19 citedOpen Access
iPSC-Derived Human Hepatocytes as a Novel Model to Investigate Thyroid Hormone Action and Signaling
Journal of the Endocrine Society·2021Open Access
Realtors as Partners in Tobacco Control: Results from a Pennsylvania Survey
Tobacco Regulatory Science·2020Open Access
page 1 of 4Next →

Frequent Co-authors

Richard W. Bohannon(7), Mary F. Hébert(4), Rose Maljanian(4), Kate Burbury(4), Joanne Wang(3), Thomas R. Easterling(3), Joanne Wang(3), Martha Ahlquist(3), Jeff Szer(3), Kazuya Maeda(3), Hiroyuki Kusuhara(3), Yuichi Sugiyama(3), Seung Jae Baek(3), Haichuan Duan(2), Chengcai Liang(2), Kenneth Rice(2), George Klein(2), Edward J. Kelly(2), David J. Wagner(2), Tapan Mehta(2)